Field Trip Health Ltd. Receives Conditional Approval to Up-List to the Toronto Stock Exchange
27 mai 2021 07h30 HE
|
Field Trip Health, Ltd.
TORONTO, May 27, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (CSE: FTRP; FTRP.WT; OTCQX: FTRPF) ("Field Trip"), a leader in the development and delivery of psychedelic therapies, is pleased to...
Former Senate Majority Leader Tom Daschle Appointed Special Adviser to Field Trip Health Ltd.
20 mai 2021 07h30 HE
|
Field Trip Health, Ltd.
TORONTO, May 20, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (CSE: FTRP; FTRP.WT; OTCQX: FTRPF) ("Field Trip"), a leader in the development and delivery of psychedelic therapies, is pleased to...
More than 80% of Americans report one or more symptoms of depression, and many have turned to substances to cope with negative emotions during COVID-19 Pandemic, according to Field Trip Health’s First Annual “State of Mind” Survey
18 mai 2021 07h30 HE
|
Field Trip Health, Ltd.
The survey conducted by YouGov Plc found that: More than 8 in 10 Americans report showing symptoms of depressionMany are turning to different substances and vices to copeWomen are bearing the brunt...
Field Trip Health Ltd. Announces DTC Eligibility
06 mai 2021 09h10 HE
|
Field Trip Health, Ltd.
TORONTO, May 06, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (CSE: FTRP; FTRP.WT; OTCQX: FTRPF) ("Field Trip"), a leader in the development and delivery of psychedelic therapies, is pleased to...
Field Trip Health Ltd. Announces Opening of Psychedelic-Enhanced Therapy Center in Houston; Locations of Next 5 Field Trip Health Centers
04 mai 2021 07h30 HE
|
Field Trip Health, Ltd.
HOUSTON, May 04, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (CSE: FTRP; FTRP.WT; OTCQX: FTRPF) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies,...
Field Trip Health Ltd. Announces Closing of $95 Million Bought Deal Financing
17 mars 2021 09h10 HE
|
Field Trip Health, Ltd.
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, March 17, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (CSE: FTRP; FTRP.WT;...
Field Trip Health Announces Upsize to Previously Announced Bought Deal Public Offering
26 févr. 2021 10h17 HE
|
Field Trip Health, Ltd.
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (CSE: FTRP; FTRP.WT; OTCQX:...
Field Trip Health Announces $50 Million Bought Deal Offering of Common Shares
25 févr. 2021 15h20 HE
|
Field Trip Health, Ltd.
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (CSE: FTRP; FTRP.WT;...
Field Trip Health Ltd. Reports Third Fiscal Quarter 2021 Financial Results
16 févr. 2021 17h30 HE
|
Field Trip Health, Ltd.
Q3 2021 patient services revenues of $316,329 represent a 235% increase over the previous quarter Field Trip continues to advance development of FT-104, a novel psychedelic molecule with pending...
Field Trip Health Ltd. Schedules Third Fiscal Quarter 2021 Financial Results Conference Call for Wednesday, February 17, 2021 at 8:00 am ET
10 févr. 2021 07h55 HE
|
Field Trip Health, Ltd.
TORONTO, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Field Trip Health Ltd. (CSE: FTRP, FTRP.WT, OTCQX: FTRPF) ("Field Trip"), a global leader in the development and delivery of psychedelic therapies,...